Laura McWhinney

Featured in: Favicon

augustafreepress.com Favicon

clinicalleader.com Favicon

pharmaceuticalonline.com Favicon

bioprocessonline.com Favicon

cellandgene.com Favicon

outsourcedpharma.com

Articles

11.02.23 -- Tales Of Outsourcing Woe

Nov 2, 2023 | outsourcedpharma.com | Louis Garguilo |Sabyasachi Ghosh |Laura McWhinney |William Powers

Interested in bringing your monoclonal antibody from transfection to GMP drug substance in nine months? Join us for a panel discussion to explore our Accelerated mAb Development Program. Meet our experts, who have developed our phase-appropriate and cost-effective program, which is scalable and integrates strategies for risk mitigation. Watch now.
10.26.23 -- 5 Best Practices For Responding To FDA Form 483 Inspection Observations

Oct 26, 2023 | clinicalleader.com | Laura McWhinney |Austin Roberts |Alisa Hummings

Webinar: Breaking Barriers — Meeting Diversity Goals In Clinical Trials Through Innovative Smart Trial Design StrategiesLearn how technology can help to identify and select the right sites and investigators for your therapeutic area as we explore strategies for tracking and reporting on your patient diversity goals. Click here to learn more. Win The Small And Emerging Sponsors’ Service ContractsWhat affects the decision made by small and emerging sponsors to engage with a service provider?
08.10.23 -- RWD/RWE Priorities For 2023

Aug 10, 2023 | clinicalleader.com | David O’Connell |Laura McWhinney

Get more clinical research insight with our FREE newsletter Newsletter | August 10, 2023 RWD/RWE In 2023: Regulatory Policy World Tour Article | By Elena Popa, Max Wegner, Patrick Brady, Vada Perkins, Shefali Goyal, and Ulrike Bodesheim, Bayer AG, DIA Learn about what the industry considers RWD/RWE priorities for the year, as well as current efforts being taken within each region around the globe. Biotech, Pharma Companies Embrace Regulatory Technology Outsourcing Article | IQVIA Integrated...
Chemistry Manufacturing and Controls (CMC) at Small Biopharma

Aug 9, 2023 | isrreports.com | Laura McWhinney

The Chemistry, Manufacturing, and Controls FunctionIn the dynamic world of biopharmaceuticals, small and emerging companies play a vital role in driving innovation and advancing groundbreaking therapies. While these companies often possess cutting-edge science and promising drug candidates, they may face unique challenges in navigating the complex regulatory landscape and bringing their products to market efficiently.
Slide Down The Funnel To Stand Out

Jun 21, 2023 | pharmaceuticalonline.com | Laura McWhinney

Article | June 21, 2023 By Laura McWhinney Evaluating brand strength is crucial as it involves assessing customer attrition throughout the purchase journey, providing valuable insights into the effectiveness of navigating the funnel. The influential rating that sets brands apart from one another is the combination of overall awareness percentage and conversion rate.
Slide Down The Funnel To Stand Out

Jun 21, 2023 | bioprocessonline.com | Laura McWhinney

Article | June 21, 2023 By Laura McWhinney Evaluating brand strength is crucial as it involves assessing customer attrition throughout the purchase journey, providing valuable insights into the effectiveness of navigating the funnel. The influential rating that sets brands apart from one another is the combination of overall awareness percentage and conversion rate.
Advancing Clinical Research With Advanced Technology

May 19, 2023 | clinicalleader.com | Laura McWhinney

By Laura McWhinney, Market Research Manager, Industry Standard Research (ISR) The pace of technological advancement often surpasses the industry's ability to adapt to it. From the days of dial-up internet to the current era of self-driving cars and pocket-sized computers, technology has rapidly transformed our lives.
Canâ€™t Stop Us Now CRO Growth Amid Uncertainty

May 19, 2023 | clinicalleader.com | Laura McWhinney

By Laura McWhinney, Market Research Manager, Industry Standard Research (ISR) Despite the global pandemic and economic uncertainty, the CRO market has been experiencing consistent growth, which is expected to continue. Factors such as the increasing number of clinical trials, increased outsourcing of research and development, and the demand for specialized services drive this market.
Win The Small And Emerging Sponsorsâ€™ Service Contracts

May 19, 2023 | clinicalleader.com | Laura McWhinney

By Laura McWhinney, Market Research Manager, Industry Standard Research (ISR) Requests for proposals (RFPs) are a well-established method for sponsors to evaluate service providers, but they require significant effort and evaluation to determine who is the best option. In addition, deciding which sponsor to pursue bids from requires a heavy investment of resources.
Predictive Power Of Perceived Leadership

Apr 5, 2023 | clinicalleader.com | Laura McWhinney

Article | April 5, 2023 By: Laura McWhinney, Market Research Manager Users in the biopharmaceutical sphere have recently shared their provider experiences and perspectives in an industry survey. This collective of information, outlined in Industry Standard Research CRO Benchmarking reports, aimed to inform sponsor organizations to make more educated CRO selections for Phase I, II, and III clinical trials.